|
Name |
Xanthoxylin
|
Molecular Formula | C10H12O4 | |
IUPAC Name* |
1-(2-hydroxy-4,6-dimethoxyphenyl)ethanone
|
|
SMILES |
CC(=O)C1=C(C=C(C=C1OC)OC)O
|
|
InChI |
InChI=1S/C10H12O4/c1-6(11)10-8(12)4-7(13-2)5-9(10)14-3/h4-5,12H,1-3H3
|
|
InChIKey |
FBUBVLUPUDBFME-UHFFFAOYSA-N
|
|
Synonyms |
Xanthoxylin; 90-24-4; Xanthoxyline; 2'-Hydroxy-4',6'-dimethoxyacetophenone; Brevifolin; 1-(2-Hydroxy-4,6-dimethoxyphenyl)ethanone; 2-Hydroxy-4,6-dimethoxyacetophenone; 1-(2-Hydroxy-4,6-dimethoxyphenyl)ethan-1-one; Brevifolin (Zanthoxylum); 2,4-Di-O-methylphloroacetophenone; Phloracetophenone dimethyl ether; Phloroacetophenone 2,4-dimethyl ether; Brevifolin (VAN); 4',6'-dimethoxy-2'-hydroxyacetophenone; 4,6-Dimethoxy-2-hydroxyacetophenone; Ethanone, 1-(2-hydroxy-4,6-dimethoxyphenyl)-; 1-Acetyl-2-hydroxy-4,6-dimethoxybenzene; Acetophenone der.; Z8RSY5TZPA; NSC 17392; 2-Acetyl-3,5-dimethoxyphenol; Acetophenone, 2'-hydroxy-4',6'-dimethoxy-; CHEBI:10070; MFCD00017243; NSC-17392; 2-Hydroxyl-4,6-dimethoxy-acetophenone; 1-(2-hydroxy-4,6-dimethoxy-phenyl)ethanone; Ethanone,1-(2-hydroxy-4,6-dimethoxyphenyl)-; UNII-Z8RSY5TZPA; 6-Methoxypaeonol; EINECS 201-978-3; Spectrum_000577; SpecPlus_000713; AI3-26010; XANTHOXYLIN [MI]; Spectrum2_000463; Spectrum3_000181; Spectrum4_001499; Spectrum5_000237; Acetophenone,6'-dimethoxy-; SCHEMBL44708; BSPBio_001701; KBioGR_002137; KBioSS_001057; SPECTRUM200441; MLS002207182; DivK1c_006809; XANTHOXYLINE [WHO-DD]; SPBio_000566; CHEMBL450288; KBio1_001753; KBio2_001057; KBio2_003625; KBio2_006193; KBio3_001201; DTXSID10237981; ZINC157077; HY-N1063; NSC17392; CCG-38702; s4781; 2-Hydroxy-4, 6-dimethoxyacetophenone; 4, 6-Dimethoxy-2-hydroxyacetophenone; AKOS015856339; SDCCGMLS-0066937.P001; 2'-hyroxy-4',6'-dimethoxyacetophenone; PHLOROACETOPHENONE DIMETHYL ETHER; NCGC00095824-01; NCGC00095824-02; AC-35124; AS-40799; SMR001306755; SY048579; 2'-Hydroxy-4',6'-dimethoxy-Acetophenone; (2-hydroxy-4,6-dimethoxy-phenyl)-ethanone; 1-(2-hydroxy-4,6-dimethoxyphenyl)-ethanone; 1-(2-Hydroxy-4,6-dimethylphenyl)-ethanone; CS-0016347; D2683; FT-0612544; 1-(2-Hydroxy-4,6-dimethoxyphenyl)ethanone #; 2'-Hydroxy-4',6'-dimethoxyacetophenone, 97%; 2',4'-DIMETHOXY-6'-HYDROXYACETOPHENONE; EN300-6477862; A843476; AQ-358/42007313; SR-05000002434; 2''-HYDROXY-4'',6''-DIMETHOXYACETOPHENONE; Acetophenone, 2'-hydroxy-4',6'-dimethoxy- (8CI); SR-05000002434-1; BRD-K12260308-001-02-6; BRD-K12260308-001-04-2; Q18210424; Z1255434817; 2 inverted exclamation mark -Hydroxy-4 inverted exclamation mark ,6 inverted exclamation mark -dimethoxyacetophenone
|
|
CAS | 90-24-4 | |
PubChem CID | 66654 | |
ChEMBL ID | CHEMBL450288 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 196.2 | ALogp: | 1.7 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 55.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 14 | QED Weighted: | 0.753 |
Caco-2 Permeability: | -4.642 | MDCK Permeability: | 0.00001630 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.047 |
Blood-Brain-Barrier Penetration (BBB): | 0.78 | Plasma Protein Binding (PPB): | 83.70% |
Volume Distribution (VD): | 0.95 | Fu: | 18.75% |
CYP1A2-inhibitor: | 0.966 | CYP1A2-substrate: | 0.924 |
CYP2C19-inhibitor: | 0.403 | CYP2C19-substrate: | 0.72 |
CYP2C9-inhibitor: | 0.201 | CYP2C9-substrate: | 0.905 |
CYP2D6-inhibitor: | 0.426 | CYP2D6-substrate: | 0.881 |
CYP3A4-inhibitor: | 0.333 | CYP3A4-substrate: | 0.319 |
Clearance (CL): | 9.963 | Half-life (T1/2): | 0.66 |
hERG Blockers: | 0.037 | Human Hepatotoxicity (H-HT): | 0.069 |
Drug-inuced Liver Injury (DILI): | 0.658 | AMES Toxicity: | 0.136 |
Rat Oral Acute Toxicity: | 0.387 | Maximum Recommended Daily Dose: | 0.108 |
Skin Sensitization: | 0.274 | Carcinogencity: | 0.041 |
Eye Corrosion: | 0.269 | Eye Irritation: | 0.984 |
Respiratory Toxicity: | 0.869 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002382 | 0.549 | D09GYT | 0.351 | ||||
ENC004779 | 0.549 | D02XJY | 0.344 | ||||
ENC002461 | 0.500 | D0E9CD | 0.314 | ||||
ENC001379 | 0.490 | D0DJ1B | 0.292 | ||||
ENC004806 | 0.465 | D05CKR | 0.288 | ||||
ENC000367 | 0.451 | D06GCK | 0.277 | ||||
ENC004830 | 0.451 | D0AN7B | 0.269 | ||||
ENC005979 | 0.444 | D08VYV | 0.264 | ||||
ENC000478 | 0.440 | D00WVW | 0.260 | ||||
ENC000764 | 0.436 | D06TQZ | 0.259 |